Osteoporosis causes a significant increase in hipbone fracture risk, simultaneously contributing to substantial defect burdens and elevated mortality in older adultsy. Fracture management and therapeutic methods with metallic implants are often limited by low-capacity bone structures, meanwhile traditional bone cements like PMMA exhibit weaknesses such as high hardening temperature and risks of thermal necrosis. Conventional bone cements are also non-degradable, slowing down bone regeneration.